LAS VEGAS, Dec. 2 /PRNewswire-FirstCall/ -- VMT Scientific Inc. (OTC:VMTF) VMT Scientific announces accomplishment of its second step in its accelerated timeline, to meet public and professional pressure for our technology. We are proud to announce the development of our upper extremity prototype is completed. Our PROOF OF CONCEPT TESTING IS EXPECTED TO BE COMPLETED BY THE END OF THE FIRST QUARTER 2006. "If these tests prove scientifically positive," states VMT's CTO, "we would expect to have several major medical research centers and companies requesting our data be privately presented to them for review." We are hoping that this will lead us to potential PRE-LICENSING NEGOTIATIONS, joint venturing and/or additional technology development of new applications for our patented technology. This Press Release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward- looking statements, particularly those risks and uncertainties inherent in the process of developing, medical products and Clinical trials. Factors that may cause such a difference include risks related to VMT Scientific Inc.'s limited operating history, risks associated with completing development and obtaining FDA medical approvals, successful patent protection and prosecution, successful sale of licensed technology nationally or internationally. VMT Scientific technology will not meet with market acceptance, the risk of future warranty and product liability claims, the uncertainty of VMT Scientifics' future access to capital to sustain operations, achieve profitability or continue as a going concern, the failure by VMT Scientific to secure and maintain relationships with suppliers, manufacturers and other third parties, reliance on key employees, and dependence on intellectual property. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. DATASOURCE: VMT Scientific, Inc. CONTACT: Catherine S. Ratelle, Director of Operations, VMT Scientific, Inc., +1-702-990-3477 Web site: http://www.vmtf.org/

Copyright